Archive for June, 2010

CSMS# 10-000148 – Elimination of the ITA Form 362P

CSMS# 10-000148 – Elimination of the ITA Form 362P
Fri, 18 Jun 2010 11:36:20 -0500

Automated Broker Interface

ITA announced in the Federal Register Notice (FRN) dated Tuesday, June 1, 2010 that the ITA form 362P is being discontinued effective May 31, 2010. With the ITA form no longer required, Electronic Invoice Program (EIP) and Remote Location Filing (RLF) participants may now file entries via EIP/RLF on imported goods that previously required the form. A copy of the FRN can be found at: http://edocket.access.gpo.gov/2010/pdf/2010-13052.pdf

Questions regarding this notice should be directed to remote.filing@dhs.gov.

Related CSMS No. 09-000343

CSMS# 10-000146 – QP In-Bond Fix Going Into Production This Weekend

CSMS# 10-000146 – QP In-Bond Fix Going Into Production This Weekend
Fri, 11 Jun 2010 11:41:45 -0500

Automated Broker Interface

On June 13, 2010 PTR 37217 will be deployed into the ACE Truck Application to resolve a QP in-bond problem that is preventing the release of a shipment on an e-manifest. This PTR will also change the way ACE processes a PAPS shipment type when both a QP in-bond and an entry are on file for the same shipment control number (SCN).

The current functionality always defaults to the QP in-bond giving priority to the QP in-bond request when both a QP in-bond and entry are on file for the same shipment control number (SCN). This fix will change this functionality to default to the QP in-bond only when the entry on file is filed for a port that is different than the port at which the e-manifest is being processed in. For example, if a truck arrived at the Port of Buffalo with a shipment and both a QP in-bond and an entry were on file for the same shipment then the system will select the entry if it is filed for the Port of Buffalo. However if the entry is for a port other then Buffalo then the QP will be linked to the shipment control number (SCN).

CSMS# 10-000145 – FDA Product Codes Changes

CSMS# 10-000145 – FDA Product Codes Changes
Thu, 10 Jun 2010 14:23:03 -0500

Automated Broker Interface

TO: All ABI Filers
FROM: Food And Drug Administration
SUBJECT: End-Dating of Industry 57 – Biological Products Product Codes

FDA has previously advised the trade the following product codes will be end-dated. See CSMS message 09-000337 dated 10/30/2009.

The codes will be end-dated on Monday, June 14, 2010, and will no longer be acceptable for transmission over the CBP/FDA Interface. Filers are encouraged to use the new product codes listed in CSMS message 09-000337 in place of those that have been end-dated.

FDA’s Center for Biologic Evaluation and Research (CBER) has published two searchable product code lists to assist filers in selecting the appropriate product code:

CBER Import Product Codes Sorted Alphabetically by Manufacturer Name

http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/ComplianceActivities/BiologicsImportingExporting/UCM196892.pdf

CBER Import Product Codes Sorted by Product Class

http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/ComplianceActivities/BiologicsImportingExporting/UCM196894.pdf

Class F is end-dated, effective 6/14/10 and replaced with new Class V.
Class O is end-dated, effective 6/14/10.

The following subclasses are end-dated, effective 6/14/10:

Subclass B – Bacterial Antigens

Subclass C – Bacterial Vaccines
Subclass D – Mod Bacterial Vaccine
Subclass E – Sens Bacterial Vaccine
Subclass F – Thera Immune Serums
Subclass G – Blood Grouping Serum
Subclass J – For Non-Clinical Research Use
Subclass K – For Educational Purposes
Subclass Y – Not Elsewhere Classified (NEC)

The following product codes are end-dated, effective 6/14/10:

57 A 01 B.Oedematiens Antitoxin
57 A 03 Diphtheria Antitoxin
57 A 04 Gas Gangrene Polyvalent Antitoxin
57 A 05 Perfringens Antitoxin
57 A 06 Staphylococcus Antitoxin
57 A 07 Tetanus Antitoxin
57 A 08 Tetanus and Gas Gangrene Polyvalent Antitoxin
57 A 12 Cobra Venom Solution
57 A 13 Cobra Venom with Silicic and Formic Acid
57 A 14 Collagenase
57 A 15 Russell Viper Venom
57 A 16 Streptokinase
57 A 17 Streptokinase-Streptodornase
57 A 18 Urokinase
57 A 19 Asparaginase Antitoxin/Antivenin/Enzyme/Venom
57 B 02 Diphtheria Toxoid, Absorbed
57 B 03 Staphylococcus Toxoid
57 B 06 Tetanus Toxoid, Absorbed
57 C 01 Adenovirus Vaccine
57 C 04 Measle, Mumps, Rubella Virus Vaccine, Live
57 C 05 Measle, Rubella Virus Vaccine, Live
57 C 06 Measle-Smallpox Vaccine, Live
57 C 07 Mumps Vaccine
57 C 10 Poliomyelitis Vaccine, Absorbed
57 C 11 Poliovirus Vaccine, Live, Oral, Trivalent
57 C 12 Poliovirus Vaccine, Live, Oral, Type 1
57 C 13 Poliovirus Vaccine, Live, Oral, Type 2
57 C 14 Poliovirus Vaccine, Live, Oral, Type 3
57 C 16 Rocky Mountain Spotted Fever Vaccine
57 C 17 Rubella and Mumps Virus Vaccine, Live
57 C 20 Typhus Vaccine
57 C 22 Measle and Mumps Virus Vaccine, Live
57 C 23 Adenovirus Vaccine, Live, Oral, Type 4
57 C 24 Adenovirus Vaccine, Live, Oral, Type 7
57 D 02 Anti-Inhibitor Coagulant Complex (Blood and Blood Derivatives)
57 D 03 Antihemophilic Factor (Human) (Blood and Blood Derivatives)
57 D 04 Antihemophilic Plasma (Human) (Blood and Blood Derivatives)
57 D 06 Factor IX Complex (Human) (Blood and Blood Derivatives)
57 D 07 Fibrinogen (Human) (Blood and Blood Derivatives)
57 D 08 Fibrinogen with Antihemophilic Factor (Human) (Blood and Blood Derivatives)
57 D 09 Fibrinolysin (Human) (Blood and Blood Derivatives)
57 D 10 Fibrinolysin and Desoxyribonuclease Combined (Bovine) (Blood and Blood Derivatives)
57 D 11 Fibrinolysin and Desoxyribonuclease Combined (Bovine) with ChloramPhenicol (Blood and Blood Derivati)

57 D 12 Histamine Azoprotein (Blood and Blood Derivatives)

57 D 13 Pepsin-Modified Immune Serum Globulin (Human) (Blood and Blood Derivatives)
57 D 14 Immune Serum Globulin (Human) (Blood and Blood Derivatives)
57 D 15 Measles Immune Globulin (Human) (Blood and Blood Derivatives)
57 D 16 Modified Plasma (Bovine) (Blood and Blood Derivatives)
57 D 17 Mumps Immune Globulin (Human) (Blood and Blood Derivatives)
57 D 19 Normal Human Plasma (Blood and Blood Derivatives)
57 D 21 Normal Rabbit Serum (Blood and Blood Derivatives)
57 D 22 Normal Serum Albumin (Human) (Blood and Blood Derivatives)
57 D 23 Pertussis Immune Globulin (Human)
57 D 24 Plasma Protein Fraction (Human) (Blood and Blood Derivatives)
57 D 25 Profibrinolysin (Human) (Blood and Blood Derivatives)
57 D 30 Red Blood Cells (Human) Frozen (Blood and Blood Derivatives)
57 D 31 Rho (D) Immune Globulin (Human) (Blood and Blood Derivatives)
57 D 33 Tetanus Immune Globulin (Human) (Blood and Blood Derivatives)
57 D 34 Thrombin, as a Drug (Blood and Blood Derivatives)
57 D 35 Vaccinia Immune Globulin (Human) (Blood and Blood Derivatives)
57 D 37 Whole Blood (Human) CPD (Blood and Blood Derivatives)
57 D 38 Whole Blood (Human) Heparin (Blood and Blood Derivatives)
57 D 39 Whole Blood (Human) Modified without Antihemophilic Factor (Blood and Blood Derivatives)
57 D 40 Blood Group Specific Substance A (Blood and Blood Derivatives)
57 D 41 Blood Group Specific Substance B (Blood and Blood Derivatives)
57 D 42 Blood Group Specific Substances A and B (Blood and Blood Derivatives)
57 D 43 Rabies Immune Globulin (Human) (Blood and Blood Derivatives)
57 D 46 Red Blood Cells (Human) Deglycerolized (Blood and Blood Derivatives)
57 D 47 Blood Group Specific Substance AB (Blood and Blood Derivatives)
57 D 48 Whole Blood Modified – Platelets Removed (Blood and Blood Derivatives)
57 D 49 Human Serum Albumin (Blood and Blood Derivatives)
57 D 50 Hepatitus Immune Globulin (Human) (Blood and Blood Derivatives)
57 D 51 Whole Blood (Human) CPDA-1 (Blood and Blood Derivatives)
57 D 52 Single Donor Plasma (Human) Platelet Rich (Blood and Blood Derivatives)
57 D 53 Single Donor Plasma (Human) Fresh/Frozen (Blood and Blood Derivatives)
57 D 54 Single Donor Plasma (Human) Liquid (Blood and Blood Derivatives)
57 D 56 Red Blood Cells (Human) Leukocytes Removed (Blood and Blood Derivatives)
57 D 57 Whole Blood (Human) Modified – Leukocytes Removed (Blood and Blood Derivatives)
57 D 58 Varicella-Zoster Immune Globln (Blood and Blood Derivatives)
57 D 59 Red Blood Cells (Human) Frozen Rejuvenated (Blood and Blood Derivatives)
57 D 60 Red Blood Cells (Human) Rejuvenated Deglycerolized (Blood and Blood Derivatives)
57 D 61 Red Blood Cells (Human) Washed (Blood and Blood Derivatives)
57 D 62 Thrombin Impregnated Pad (Blood and Blood Derivatives)
57 E 01 Blastomycin (In-Vivo Diagnostic Products)
57 E 03 Coccidioidin (In-Vivo Diagnostic Products)
57 E 04 Diphtheria Toxin for Schick Test (In-Vivo Diagnostic Products)
57 E 05 Histoplasmin (In-Vivo Diagnostic Products)
57 E 06 Lymphogranuloma Venereum Antigen (In-Vivo Diagnostic Products)
57 E 07 Mumps Skin Test Antigen (In-Vivo Diagnostic Products)
57 E 08 Schick Test Control (In-Vivo Diagnostic Products)
57 E 09 Tuberculin, Old (In-Vivo Diagnostic Products)
57 E 11 Albumin (Human) Aggregated Radio-Iodinated (I-131) (In-Vivo Diagnostic Products)
57 E 12 Albumin Microspheres (Human) (In-Vivo Diagnostic Products)
57 E 13 Serum Albumin (Human), Radio- Chromated (Cr-51) (In-Vivo Diagnostic Products)
57 E 14 Serum Albumin (Human), Radio-Iodinated (I-125) (In-Vivo Diagnostic Products)
57 E 15 Serum Albumin (Human), Radio-Iodinated (I-131) (In-Vivo Diagnostic Products)
57 E 16 Albumin (Human), Aggregated Technetated (99mTc) (In-Vivo Diagnostic Products)
57 E 17 Trichinella Extract (In-Vivo Diagnostic Products)
57 E 18 Albumin (Human), Aggregated (In-Vivo Diagnostic Products)
57 E 19 Diphtheria Toxoid-Schick Test Control (In-Vivo Diagnostic Products)
57 E 20 Iodine 123 (In-Vivo Diagnostic Products)
57 F 99 In-Vitro Diagnostic Products, N.E.C
57 F 01 Anti-A1 (Blood Grouping Serum)
57 F 02 Anti-A (Blood Grouping Serum)
57 F 03 Anti-B (Blood Grouping Serum)
57 F 04 Anti-A,B (Blood Grouping Serum)
57 F 05 Anti-Dia (Blood Grouping Serum)
57 F 06 Anti-Fya (Blood Grouping Serum)
57 F 07 Anti-Fyb (Blood Grouping Serum)
57 F 08 Anti-Human Chorionic Gonadotrop Serum (In-Vitro Diagnostic Products)
57 F 09 Anti-Human Serum (In-Vitro Diagnostic Products)
57 F 10 Anti-Influenza Virus Serum (Hemagglutination Inhibition Test) (In-Vitro Diagnostic Products)
57 F 11 Anti-I (Blood Grouping Serum)
57 F 12 Anti-Jka (Blood Grouping Serum)
57 F 13 Anti-Jkb (Blood Grouping Serum)
57 F 14 Anti-Jsb (Blood Grouping Serum)
57 F 15 Anti-k (Small K) (Blood Grouping Serum)
57 F 16 Anti-K (Capital K) (Blood Grouping Serum)
57 F 17 Anti-Kpa (Blood Grouping Serum)
57 F 18 Anti-Kpb (Blood Grouping Serum)
57 F 19 Anti-Lea (Human) (Blood Grouping Serum)
57 F 20 Anti-Leb (Human) (Blood Grouping Serum)
57 F 21 Anti-Lua (Blood Grouping Serum)
57 F 22 Anti-M (Human) (Blood Grouping Serum)
57 F 23 Anti-Mg (Blood Grouping Serum)
57 F 24 Anti-Mia (Blood Grouping Serum)
57 F 25 Anti-N (Human) (Blood Grouping Serum)
57 F 26 Anti-P1 (Human) (Blood Grouping Serum)
57 F 27 Anti-Cob (Human) (Blood Grouping Serum)
57 F 28 Anti-D (High Protein) (Blood Grouping Serum)
57 F 29 Anti-CD (High Protein) (Blood Grouping Serum)
57 F 30 Anti-DE (High Protein) (Blood Grouping Serum)
57 F 31 Anti-CDE (High Protein) (Blood Grouping Serum)
57 F 32 Anti-C (High Protein) (Blood Grouping Serum)
57 F 33 Anti-E (High Protein) (Blood Grouping Serum)
57 F 34 Anti-c (Small C)(High Protein) (Blood Grouping Serum)
57 F 35 Anti-e (Small E)(High Protein) (Blood Grouping Serum)
57 F 36 Anti-V (Blood Grouping Serum)
57 F 37 Anti-Cw (High Protein) (Blood Grouping Serum)
57 F 38 Anti-S (Blood Grouping Serum)
57 F 39 Anti-s (Small S) (Blood Grouping Serum)
57 F 40 Anti-U (Blood Grouping Serum)
57 F 41 Anti-Xga (Blood Grouping Serum)
57 F 42 Anti-A For Automated Systems (Blood Grouping Serum)
57 F 43 Anti-B For Automated Systems (Blood Grouping Serum)
57 F 44 Anti-A,B For Automated Systems (Blood Grouping Serum)
57 F 45 Anti-D For Automated Systems (Blood Grouping Serum)
57 F 46 Anti-Cd For Automated Systems (Blood Grouping Serum)
57 F 47 Anti-De For Autmd Sys
57 F 48 Anti-CDE For Automated Systems (Blood Grouping Serum)
57 F 49 Anti-c (Small C) For Automated Systems (Blood Grouping Serum)
57 F 50 Haemophilus Influenzae Typing Serum (In-Vitro Diagnostic Products)
57 F 51 Hepatitis Associated Antibody (Anti-Australia Antigen) (In-Vitro Diagnostic Products)
57 F 52 Influenzae Virus Hemagglutinating Antigen (In-Vitro Diagnostic Products)
57 F 53 Reagent Red Blood Cells (In-Vitro Diagnostic Products)
57 F 54 Leukocyte Typing Serum (In-Vitro Diagnostic Products)
57 F 55 Anti-Carcinoembryo Antigenic Serum (In-Vitro Diagnostic Products)
57 F 56 Hepatitis B Surface Antigen (In-Vitro Diagnostic Products)
57 F 57 Reagent Red Blood Cells for Automated Systems (In-Vitro Diagnostic Products)
57 F 58 Limulus Amchocyte Lysate (In-Vitro Diagnostic Products)
57 F 60 Anti-D (Saline Active) (Blood Grouping Serum)
57 F 61 Anti-C (Saline Active) (Blood Grouping Serum)
57 F 62 Anti-E (Saline Active) (Blood Grouping Serum)
57 F 63 Anti-c (Small C) (Saline Active) (Blood Grouping Serum)
57 F 64 Anti-e (Small E) (Saline Active) (Blood Grouping Serum)
57 F 65 Anti-Cw (Saline Active) (Blood Grouping Serum)
57 F 66 Anti-Lea (Goat) (Blood Grouping Serum)
57 F 67 Anti-Leb (Goat) (Blood Grouping Serum)
57 F 68 Anti-M (Rabbit) (Blood Grouping Serum)
57 F 69 Anti-N (Rabbit) (Blood Grouping Serum)
57 F 70 Anti_P1 (Goat) (Blood Grouping Serum)
57 F 71 Anti-Human Serum, Anti-IgG (In-Vitro Diagnostic Products)
57 F 73 Anti-Mg (Saline Active) (Blood Grouping Serum)
57 F 74 Anti-Human Serum, Anti C3d (Mouse Hybridoma) (Blood Grouping Serum)
57 F 87 Antibody to Hepatitis A Virus (In-Vitro Diagnostic Products)
57 F 88 Antibody to Hepatitis B Core Antigen (In-Vitro Diagnostic Product)
57 F 89 Hepatitis B Core Antigen (In-Vitro Diagnostic Products)
57 F 90 Hepatitis A Virus (In-Vitro Diagnostic Products)
57 F 91 Blood Grouping Reagent(s)
57 G 02 Allergenic Extracts Alum Precipitated (Allergenic Products)
57 G 12 Poison Ivy Extract (Allergenic Products)
57 G 13 Poison Ivy Extract Alum Precipitated (Allergenic Products)
57 G 14 Poison Ivy-Oak-Sumac Extracts Combined (Allergenic Products)
57 G 15 Poison Ivy-Oak Extracst Combined (Allergenic Products)
57 G 16 Poison Oak Extract (Allergenic Products)
57 G 17 Poison Sumac Extract (Allergenic Products)
57 G 60 Anti-D(Saline Active)
57 H 33 Cholera Vaccine (Bacterial Vaccines)
57 H 13 Pseudomonas Polysaccaride (Bacterial Antigen)
57 H 34 Pertussis Vaccine (Bacterial Vaccines)
57 H 35 Pertussis Vaccine, Adsorbed (Bacterial Vaccines)
57 H 40 Meningococcal Polysaccharide Vaccine, Group A (Bacterial Vaccines)
57 H 41 Meningococcal Polysaccharide Vaccine, Groups A,C (Bacterial Vaccines)
57 H 43 Meningococcal Polysaccharide Vaccine, Group Y (Bacterial Vaccines)
57 H 51 Polyvalent Modified Bacterial Antigen (No U.S. Standard Potency)
57 H 81 Anti-Hemophilus Influenzae Type b (Small B) Serum (Therapeutic Immune Serums)
57 H 82 Antirabies Serum (Therapeutic Immune Serums)
57 H 83 Streptococuss Vaccine (Therapeutic Immune Serums)
57 I 01 Adenovirus and Influenzae Virus Vaccines Combined, Aluminum Phosphate Adsorbed
57 I 02 Diphtheria and Tetanus Toxoid (Multiple Antigen Preparations)
57 I 03 Diphtheria and Tetanus Toxoid, Adsorbed (Multiple Antigen Preparations)
57 I 04 Diphtheria, Tetanus and Pertussis Vaccine (Multiple Antigen Preparations)
57 I 06 Diptheria, Tetanus and Pertussis Vaccine and Polio (Multiple Antigen Preparations)
57 I 07 Diphtheria, Tetanus, Pertussis and Polio Vaccine, Absorbed (Multiple Antigen Preparations)
57 I 08 Diphtheria Toxoid and Pertussis Vaccine, Adsorbed (Multiple Antigen Preparations)
57 I 09 Staph Toxoid and Bacterial Antigen made from Staph (Albus and Aureus)
57 J 01 Fascia (Human Musculoskeletal Tissues)
57 J 02 Cartilage (Human Musculoskeletal Tissues)
57 J 04 Ligaments (Human Musculoskeletal Tissues)
57 J 05 Tendons (Human Musculoskeletal Tissues)
57 J 06 Vascular Graft (Human Musculoskeletal Tissues)
57 L 01 Cornea (Human Ocular Tissues)
57 L 02 Sclera (Human Ocular Tissues)
57 N 01 Somatic Cells (Human Tissue, Cellular Therapies)
57 N 02 Cell & Gene Therapies (Human Tissue, Cellular Therapies)
57 O 01 Skin (Human Tissue, Other Tissues)
57 O 02 Pericardium (Human Tissue, Other Tissues)

Related CSMS No. 09-000337

CSMS# 10-000140 – ACH Debit Transmissions from 5/27/10

CSMS# 10-000140 – ACH Debit Transmissions from 5/27/10
Wed, 02 Jun 2010 16:01:04 -0500

Automated Broker Interface

The National Finance Center encountered a problem with the ACH Debit transmissions on Thursday, may 27, 2010. Because of this issue, the payments for those statements that were authorized on that date have not yet been debited from the individual accounts. The correction has been made but it may take up to two business days before the trade will see the funds deducted from their accounts.

We apologize for any inconvenience.

CSMS# 10-000137 – ACE Frequently Asked Questions (FAQ) document has been posted to CBP.gov

CSMS# 10-000137 – ACE Frequently Asked Questions (FAQ) document has been posted to CBP.gov
Tue, 01 Jun 2010 12:19:45 -0500

Truck Manifest

CBP has posted a comprehensive ACE Frequently Asked Questions document on CBP.gov. This document provides answers to questions on new ACE Entry Summary, Accounts and Revenue capabilities (A1, A2.2 and A2.3.1); general ACE information; ACE account application process; ACE Portal account functionality; periodic monthly statement filing; electronic truck manifest, and reports.

To access the web page containing this FAQ document, cut and paste the following link to your browser:

http://www.cbp.gov/xp/cgov/trade/automated/modernization/ace/

Related CSMS No. 10-000137

CSMS# 10-000135 – May 2010 Trade Account Owner Update

CSMS# 10-000135 – May 2010 Trade Account Owner Update
Tue, 01 Jun 2010 07:50:01 -0500

Automated Broker Interface

Attached is the May 2010 Trade Account Owner Update for your information. Please share with all users of your ACE account. Thank you.

Note that supplemental information to this message is available in the form of one or more file downloads.
Please follow the link in this email message to the CSMS web site to access this information.